Results 331 to 340 of about 754,612 (422)

The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease. [PDF]

Clin Rheumatol
Temiz Karadag D, Dogan S, Cakir O, Altıntas Y, Yilmaz S, Gökcen N, Yazici A, Cefle A.   +7 more
europepmc   +1 more source

Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments

Med Research, EarlyView.
ABSTRACT The immune microenvironment includes immune cells, cytokines, extracellular matrix, vesicles, etc. The interactions between these components form a unique local immune microecology. Although immunity serves as the defense against external pathogens, aberrant immune activation often contributes to disease development.
Guoqing Li, Yuxuan Wan, Alan Jiao, Ke Jiang, Gaoyuan Cui, Jinxin Tang, Simin Yu, Zhengang Hu, Songfeng Zhao, Zhenjie Yi, Lifu Long, Yang Yang, Xuehao Cui, Chunrun Qu   +13 more
wiley   +1 more source

Intractable complication of collagen disease. Advances in diagnosis and treatment. I. Pathological change of lung. 2. Interstitial pneumonia.

, 2001
山田 秀裕, 山前 正臣, 山崎 宜興, 加勢 千容, 浜 信昭   +4 more
openalex   +2 more sources

Effect of Natural Polyphenols on Breast Cancer Chemoprevention and Treatment

Molecular Nutrition &Food Research, EarlyView.
Effect of Natural Polyphenols on Breast Cancer proliferation and progression. ABSTRACT Breast cancer is the most common type of malignancy among women worldwide. Significant achievements have been made in diagnostic tools and cancer treatments in the past decade; however, the complexity and heterogeneity of certain breast cancer subtypes often lead to ...
Marzia Sichetti, Martina Giuseffi, Eugenia Giglio, Graziella Marino, Marisabel Mecca   +4 more
wiley   +1 more source

Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis-a prospective cohort study. [PDF]

Front Med (Lausanne)
Colic J, Pruner I, Damjanov N, Antovic J, Sefik-Bukilica M, Cerinic MM, Antovic A.   +6 more
europepmc   +1 more source

Avoiding early diagnosis

Journal of General and Family Medicine, EarlyView.
Takao Wakabayashi, Goh Keng Wee, Mikinosuke Ishibashi, Yoshiki Akiyama, Naoki Kanda, Tomoyuki Watanabe   +5 more
wiley   +1 more source

Simultaneous T1, T2, and T1ρ mapping of the myocardium using cardiac MR fingerprinting with a deep image prior reconstruction

Magnetic Resonance in Medicine, EarlyView.
Abstract Purpose To develop a cardiac MR fingerprinting (cMRF) approach using deep image prior reconstruction (DIP) to simultaneously map T1, T2, and T1ρ, and assess T1ρ in healthy subjects and patients with areas of enhancement on late gadolinium enhancement.
Sydney Kaplan, Gastao Lima da Cruz, Chaitanya Madamanchi, Venkatesh L. Murthy, Scott Swanson, Jesse Hamilton, Nicole Seiberlich   +6 more
wiley   +1 more source

Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease. [PDF]

J Pers Med
Kanaji N, Watanabe N, Inoue T, Mizoguchi H, Komori Y, Ohara Y, Kadowaki N.   +6 more
europepmc   +1 more source

Post‐COVID‐19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies

The Journal of Pathology, EarlyView.
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk, Guolu Tang, Arno R Bourgonje, Wilfred FA den Dunnen, Jan‐Luuk Hillebrands, Harry van Goor   +5 more
wiley   +1 more source

Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease. [PDF]

Medicina (Kaunas)
Takahashi T, Saito A, Yorozuya T, Nishikiori H, Kuronuma K, Chiba H.   +5 more
europepmc   +1 more source